Neurodiagnostics in Public Health: Cognitive Decline, Mental Health, and Emerging Technologies
A special issue of Healthcare (ISSN 2227-9032).
Deadline for manuscript submissions: 31 December 2025 | Viewed by 1942
Special Issue Editors
Interests: clinical psychology; neuropsychology; cognitive neuroscience; psychopathology; neuroeducation; psychotherapeutic processes; applied psychology
Special Issues, Collections and Topics in MDPI journals
Interests: environmental health; environmental microbiology; epidemiology of foodborne and waterborne diseases; risk assessment; molecular epidemiology; environmental virology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurocognitive disorders such as dementia, mild cognitive impairment (MCI), and neuropsychiatric diseases are increasing globally and impose a substantial burden on healthcare systems and public health policy. Their detection in the earliest stages and precise diagnosis are important for early intervention and better patient outcomes.
This Special Issue covers the interface between neurodiagnostics, public health, and cognitive neuroscience with a focus on new diagnostic approaches, psychological testing, and influences of environmental and epidemiological factors on cognitive capacity. Developments in biomarkers, artificial intelligence, digital diagnosis, and public health interventions provide encouraging avenues for early detection and intervention.
We invite original studies, systematic reviews, and clinical case studies examining novel diagnostic strategies that harness the strengths of neuropsychology, cognitive neuroscience, and public health frameworks.
Topics of Interest Include:
- Cognitive Neuroscience and Neuropsychology:
- Novel neuropsychological tools for early cognitive impairment detection;
- The relationship between cognitive decline and psychiatric disorders (e.g., depression, anxiety, or schizophrenia);
- Cognitive dysfunction in post-viral syndromes (e.g., post-COVID-19 cognitive impairment).
- Biomarkers and Imaging in Neurodiagnostics:
- Advances in neuroimaging (fMRI, PET, EEG) for diagnosing cognitive disorders;
- Blood-based and cerebrospinal fluid biomarkers for neurodegenerative diseases;
- Multi-omics approaches (genomics, proteomics, and metabolomics) in cognitive decline.
- Public Health and Epidemiological Aspects of Cognitive Decline:
- Environmental risk factors for cognitive impairment (air pollution, toxins, or infections);
- Public health screening programs for the early detection of dementia and neurodegenerative diseases;
- Socioeconomic and lifestyle determinants of cognitive health.
- Digital and AI-Driven Diagnostics:
- AI and machine learning applications in cognitive assessment and early diagnosis;
- Wearable and mobile technologies for cognitive monitoring;
- Digital biomarkers and remote neuropsychological testing.
By bringing together cognitive neuroscience, clinical neuropsychology, and public health, this Special Issue seeks to drive early diagnostic solutions for neurocognitive and neuropsychiatric disorders. It will deliver a roadmap for how interdisciplinarity can lead to more accurate, affordable, and scalable diagnostics.
You may choose our Joint Special Issue in Diagnostics.
Dr. Evgenia Gkintoni
Prof. Dr. Apostolos Vantarakis
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurocognitive disorders
- dementia
- mild cognitive impairment (MCI)
- neuropsychiatric diseases
- biomarkers
- imaging
- artificial intelligence
- digital diagnosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
